                         SEQUENCE LISTING

<110>  Universit Pierre et Marie Curie (Paris 6) et al
 
<120>  CELL PENETRATING PEPTIDES

<130> B1290PC

<160>  18    

<170>  PatentIn version 3.3

<210>  1
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is vacant, is a lysine residue, or valine-lysine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is an amino acid residue that is different from arginine and 
       is non-conservative with respect to arginine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is vacant, is a lysine residue, or lysine-isoleucine

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is vacant or is an amino acid sequence of one to 4 amino 
       acids

<400>  1

Xaa Lys Lys Lys Ile Lys Xaa Glu Ile Xaa Xaa 
1               5                   10      


<210>  2
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  2

Val Lys Lys Lys Lys Ile Lys Ala Glu Ile Lys Ile 
1               5                   10          


<210>  3
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is valine or isoleucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is aspartic acid or glycine

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is phenylalanine or leucine

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa is arginine or histidine

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is vacant or is glutamate, or glutamate-aspartate, or 
       glutamate-aspartate-leucine

<400>  3

Tyr Xaa Glu Thr Leu Asp Xaa Ile Xaa Glu Gln Trp Ala Xaa Ser Xaa 
1               5                   10                  15      


<210>  4
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  4

Val Lys Lys Lys Lys Ile Lys Ala Glu Ile Lys Ile Tyr Val Glu Thr 
1               5                   10                  15      


Leu Asp Asp Ile Phe Glu Gln Trp Ala His Ser Glu Asp Leu 
            20                  25                  30  


<210>  5
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  5

Val Lys Lys Lys Lys Ile Lys Ala Glu Ile Lys Ile Tyr Ile Glu Thr 
1               5                   10                  15      


Leu Asp Asp Ile Leu Glu Gln Trp Ala Arg Ser Glu Asp Leu 
            20                  25                  30  


<210>  6
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  6

Val Lys Lys Lys Lys Ile Lys Arg Glu Ile Lys Ile Tyr Val Glu Thr 
1               5                   10                  15      


Leu Asp Asp Ile Phe Glu Gln Trp Ala His Ser Glu Asp Leu 
            20                  25                  30  


<210>  7
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  7

Val Lys Lys Lys Lys Ile Lys Arg Glu Ile Lys Ile 
1               5                   10          


<210>  8
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  8

Asp Thr Leu Asp His Ile Arg Ala Leu Asp Arg Leu Gln Glu Val Pro 
1               5                   10                  15      


His Glu Gly Pro 
            20  


<210>  9
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  9

Asp Thr Leu Asp His Ile Arg Ala Leu Asp Arg Leu Gln Glu Val Pro 
1               5                   10                  15      


His Glu Gly Pro 
            20  


<210>  10
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  10

Val Lys Lys Lys Lys Ile Lys Lys Glu Ile Lys Ile 
1               5                   10          


<210>  11
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  11

Val Lys Lys Lys Lys Ile Lys Asn Glu Ile Lys Ile 
1               5                   10          


<210>  12
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  12

Val Lys Lys Lys Lys Ile Lys Lys Glu Ile Lys Ile Tyr Val Glu Thr 
1               5                   10                  15      


Leu Asp Asp Ile Phe Glu Gln Trp Ala His Ser Glu Asp Leu 
            20                  25                  30  


<210>  13
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  13

Val Lys Lys Lys Lys Ile Lys Lys Glu Ile Lys Ile Tyr Ile Glu Thr 
1               5                   10                  15      


Leu Asp Asp Ile Leu Glu Gln Trp Ala Arg Ser Glu Asp Leu 
            20                  25                  30  


<210>  14
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  14

Val Lys Lys Lys Lys Ile Lys Asn Glu Ile Lys Ile Tyr Val Glu Thr 
1               5                   10                  15      


Leu Asp Asp Ile Phe Glu Gln Trp Ala His Ser Glu Asp Leu 
            20                  25                  30  


<210>  15
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cell penetrating peptide

<400>  15

Val Lys Lys Lys Lys Ile Lys Asn Glu Ile Lys Ile Tyr Ile Glu Thr 
1               5                   10                  15      


Leu Asp Asp Ile Leu Glu Gln Trp Ala Arg Ser Glu Asp Leu 
            20                  25                  30  


<210>  16
<211>  32
<212>  PRT
<213>  Artificial

<220>
<223>  chimeric peptide

<400>  16

Val Lys Lys Lys Lys Ile Lys Ala Glu Ile Lys Ile Asp Thr Leu Asp 
1               5                   10                  15      


His Ile Arg Ala Leu Asp Arg Leu Gln Glu Val Pro His Glu Gly Pro 
            20                  25                  30          


<210>  17
<211>  32
<212>  PRT
<213>  Artificial

<220>
<223>  chimeric peptide

<400>  17

Val Lys Lys Lys Lys Ile Lys Lys Glu Ile Lys Ile Asp Thr Leu Asp 
1               5                   10                  15      


His Ile Arg Ala Leu Asp Arg Leu Gln Glu Val Pro His Glu Gly Pro 
            20                  25                  30          


<210>  18
<211>  32
<212>  PRT
<213>  Artificial

<220>
<223>  chimeric peptide

<400>  18

Val Lys Lys Lys Lys Ile Lys Asn Glu Ile Lys Ile Asp Thr Leu Asp 
1               5                   10                  15      


His Ile Arg Ala Leu Asp Arg Leu Gln Glu Val Pro His Glu Gly Pro 
            20                  25                  30          


